FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

K Shannon

Research Profile

Chemicals & Drugs

Procedures

Physiology

Living Beings

Disorders

Klebsiella Infections

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Co-Publications
Name
9
Ian Phillips
6
Gary French
1
A King
1
Barry Cookson

Publications

TOP 3
K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; Barry D Cookson; Gary L French
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.
K Shannon; K Fung; P Stapleton; R Anthony; E Power; Gary L French
A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance.
J May; K Shannon; A King; Gary L French
Glycopeptide tolerance in Staphylococcus aureus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of K Shannon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1998: K Shannon; P Stapleton; X Xiang; A Johnson; H Beattie; F El Bakri; Barry D Cookson; Gary L French
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.
Journal of clinical microbiology 1998;36(10):3105-10.
1998: K Shannon; K Fung; P Stapleton; R Anthony; E Power; Gary L French
A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance.
The Journal of hospital infection 1998;39(4):291-300.
1998: J May; K Shannon; A King; Gary L French
Glycopeptide tolerance in Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1998;42(2):189-97.
1997: X Xiang; K Shannon; Gary L French
Mechanism and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae.
The Journal of antimicrobial chemotherapy 1997;40(4):525-32.
1997: M Leung; K Shannon; Gary L French
Rarity of transferable beta-lactamase production by Klebsiella species.
The Journal of antimicrobial chemotherapy 1997;39(6):737-45.
1995: A King; K Shannon; Ian Phillips
Resistance to imipenem in Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1995;36(6):1037-41.
1995: P J Wu; K Shannon; Ian Phillips
Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli.
The Journal of antimicrobial chemotherapy 1995;36(6):927-39.
1995: P Stapleton; K Shannon; Ian Phillips
DNA sequence differences of ampD mutants of Citrobacter freundii.
Antimicrobial agents and chemotherapy 1995;39(11):2494-8.
1995: P Stapleton; P J Wu; A King; K Shannon; Gary L French; Ian Phillips
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
Antimicrobial agents and chemotherapy 1995;39(11):2478-83.
1994: P J Wu; K Shannon; Ian Phillips
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
Antimicrobial agents and chemotherapy 1994;38(3):494-8.
1993: Ian Phillips; K Shannon
Importance of beta-lactamase induction.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12 Suppl 1():S19-26.
1992: P J Wu; K Shannon; Ian Phillips
beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli.
The Journal of antimicrobial chemotherapy 1992;30(6):868-71.
1992: K Shannon; A King; Ian Phillips
Prevalence of resistance to beta-lactam antibiotics in Escherichia coli isolated from blood from 1969-1991.
The Journal of antimicrobial chemotherapy 1992;30(5):661-72.
1981: Ian Phillips; C Warren; K Shannon; A King; D Hanslo
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
The Journal of antimicrobial chemotherapy 1981;8 Suppl B():23-31.